G418 - 50mg/mL

G418 - 50mg/mL


Order number: M3118.0020

Shipping: Shipment: not cooled. Store at +2°C to +8°C. For laboratory usage only!
CAS-Nr: 108321-42-2

Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.

€66.75 *

Volume:

Please select the favoured pack size.

G418 also known as Geneticin(TM), is an aminoglycoside antibiotic that inhibits protein... more
Product information "G418 - 50mg/mL"

G418 also known as Geneticin(TM), is an aminoglycoside antibiotic that inhibits protein synthesis in mammalian cells by interfering with ribosomal function. G418 shows a structure similar to gentamycin > and kanamycin > and finds application in the selection of stably transformed cells expressing the neomycin resistance gene (aminoglycoside) of transposons Tn 5 or Tn 601.

Because G418 is toxic for many cells, the optimum concentration for each cell type has to be determined. It is usually between 50ug/mL and 1000μg/mL. At a concentration of 500μg/mL, for example, 70% of HepG2 cells are killed after incubation for one week and 100% will stop their growth. Since potency of the antibiotic can vary from batch to batch, it is recommended to create large stocks of a batch tested to standardize the system.

Cells divide still once or twice in the presence of the lethal dose of G418, so that a selection effect will be visible only after several days. Geneticin is a registered trademark of Gibco, a Division of Life Technologies.

Genaxxon's G418 is an alternative to ThermoFisher / Invitrogen product no. 10131035 and 10131027, or a replacement for BioChrom product no.: A 2812.

Genaxxon bioscience offers a broad range of Antibiotics and Antimycotics as powder or solutions.

More products around "G418 - 50mg/mL"
Our comment on "G418 - 50mg/mL"
G418 inhibits protein synthesis in mammalian cells by interfering with ribosomal function.
Specifications: 50 mg/mL sterile filtered solution C20H40N4O10x2H2SO4 MW = 692.7 g/mol Liquid... more
 

Technical Data:

Specifications:
50 mg/mL sterile filtered solution
C20H40N4O10x2H2SO4
MW = 692.7 g/mol
Liquid formulation of Cat#: M3117

Harmful: LD50 of <2000 mg/kg. May be carcinogen/teratogenic.

application:

Selection of stably transformed cells expressing the neomycin resistance gene (aminoglycoside) of transposons Tn 5 or Tn 601.

Source

seaweed

Sicherheits Hinweise / Safety

H-Sätze: H301
R-Sätze: R61
Gefahrstoffkürzel: T

Klassifizierungen / Classification

CAS-Nr: 108321-42-2
eclass-Nr: 32-19-90-90
Dokumente - Protokolle - Downloads more


Dokumente - Protokolle - Downloads

Here you will find information and further literature on G418 - 50mg/mL. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.

 
 
 
Dokumente - Protokolle - Downloads more

Dokumente - Protokolle - Downloads

Genaxxon's G418 is an alternative to ThermoFisher / Invitrogen product no. 10131035 and 10131027, or a replacement for BioChrom product no.: A 2812.

Do not use G418 together wirh anitbiotic/antifungal preparations (e.g. Pen/Strep). These agents are competitive inhibitors of G418. Other antibiotics are potentially cross-reactive as well.

Working concentrations:

Cell type          Selection concentration (mg/mL)
HeLa               200 - 600
3T3 cells         500 - 1000
CHO               200 - 400
HEK 293        500 - 800
Jurkat cells     600 - 700

 
 
 
Literatur .... more

Referenzen..

Hier finden Sie Artikel und Literaturzitate, in denen die Autoren auf die hohe Qualität dieses Genaxxonprodukts vertrauen.
Listed below are articles and references, in which the authors trust in the high quality of this Genaxxon product.

Quelle/Source: NCBI PubMed >

 

IL-23R Signaling Plays No Role in Myocardial Infarction
Erika Engelowski, Nastaran Fazel Modares, Simone Gorressen, Pascal Bouvain, Dominik Semmler, Christina Alter, Zhaoping Ding, Ulrich Flögel, Jürgen Schrader, Haifeng Xu, Philipp A. Lang, Jens Fischer, Doreen M. Floss, Jürgen Scheller
Sci Rep. 2018; 8: 17078. Published online 2018 Nov 20. doi: 10.1038/s41598-018-35188-8
PMCID: PMC6244091

Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases

Doreen M. Floss, Tobias Klöcker, Jutta Schröder, Larissa Lamertz, Simone Mrotzek, Birgit Strobl, Heike Hermanns, Jürgen Scheller

Mol Biol Cell. 2016 Jul 15; 27(14): 2301–2316. doi: 10.1091/mbc.E14-12-1645

PMCID: PMC4945146

MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR

Claudia J. Krause, Oliver Popp, Nanthakumar Thirunarayanan, Gunnar Dittmar, Martin Lipp, Gerd Müller

Oncotarget. 2016 Mar 1; 7(9): 10414–10432. Published online 2016 Feb 8. doi: 10.18632/oncotarget.7248

PMCID: PMC4891129

Non-Canonical Interleukin 23 Receptor Complex Assembly: P40 PROTEIN RECRUITS INTERLEUKIN 12 RECEPTOR β1 VIA SITE II AND INDUCES P19/INTERLEUKIN 23 RECEPTOR INTERACTION VIA SITE III

Jutta Schröder, Jens M. Moll, Paul Baran, Joachim Grötzinger, Jürgen Scheller, Doreen M. Floss

J Biol Chem. 2015 Jan 2; 290(1): 359–370. Published online 2014 Nov 4. doi: 10.1074/jbc.M114.617597

PMCID: PMC4281739

Alternative Intronic Polyadenylation Generates the Interleukin-6 Trans-signaling Inhibitor sgp130-E10

Jan Sommer, Christoph Garbers, Janina Wolf, Ahmad Trad, Jens M. Moll, Markus Sack, Rainer Fischer, Joachim Grötzinger, Georg H. Waetzig, Doreen M. Floss, Jürgen Scheller

J Biol Chem. 2014 Aug 8; 289(32): 22140–22150. Published online 2014 Jun 27. doi: 10.1074/jbc.M114.560938

PMCID: PMC4139227